ArticleMolecular genetics & genomic medicine2026
Prenatal Etiology Diagnosis of Rare Compound Heterozygous PROC Gene Variants in a Fetus With Ocular Ultrasonic Anomaly Using Whole Exome Sequencing.
Article in Molecular genetics & genomic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThis study aims to present novel compound heterozygous PROC gene variants in a fetus. These variants cause protein C deficiency-associated thrombophilia and are accompanied by prenatal ocular anomalies in the affected fetus.
methodsA fetus presenting with prenatal ocular ultrasound anomalies was enrolled for genetic prenatal diagnosis. Trio whole-exome sequencing (WES) was performed on the fetus and parental samples to explore the genetic etiology. Sanger sequencing was subsequently applied to verify the identified genetic variants.
resultsWES result revealed two likely pathogenic compound heterozygous variants NM_000312.4: c.[378G>A(p.W126*)]; [658C>T(p.R220W)] in PROC gene in the fetus, which were inherited from the parents, respectively. Notably, a likely pathogenic homozygous variant of NM_176824.3:c.728G>A(p.C243Y) in BBS7 gene, and a heterozygous variant of NM_012193.4:c.112G>A(p.G38R) in FZD4 gene, as well as a pathogenic heterozygous variant of NM_000435.3:c.1630C>T(p.R544C) in NOTCH3 gene were observed in the mother, which may explain her clinical abnormalities. The maternal BBS7 variant was transmitted to the fetus, whereas the FZD4 and NOTCH3 variants were not detected in the proband. The father exhibited a clinical phenotype of cleft lip and palate, but no corresponding pathogenic genetic variants were identified.
conclusionThis study first reports two rare compound heterozygous PROC variants in a Chinese fetus, which expands the mutational spectrum of protein C deficiency-related thrombophilia in the Chinese population. Furthermore, our findings highlight the robust clinical application value of trio-WES in the etiological diagnosis of complex prenatal genetic disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.